Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Silver

Showing results (381-390 of 428) with videos related to

Pageof 43
Sort By:
International Journal of Molecular Medicine|September 3, 2011
Inhibition of experimental auto-immune uveitis by the A3 adenosine receptor agonist CF101Sara Bar-Yehuda, Dror Luger, Avivit Ochaion, et al.
Journal of Autoimmunity|May 14, 2019
Interleukin 22 ameliorates neuropathology and protects from central nervous system autoimmunityMary J Mattapallil, Jennifer L Kielczewski, Carlos R Zárate-Bladés, et al.
Plos One|August 24, 2016
Environmental DNA Marker Development with Sparse Biological Information: A Case Study on Opossum Shrimp (Mysis diluviana)Kellie J Carim, Kyle R Christianson, Kevin M McKelvey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 13, 2012
The living eye "disarms" uncommitted autoreactive T cells by converting them to Foxp3(+) regulatory cells following local antigen recognitionRu Zhou, Reiko Horai, Phyllis B Silver, et al.
Experimental Gerontology|October 16, 2012
Curcumin is an early-acting stage-specific inducer of extended functional longevity in DrosophilaJung-Won Soh, Nicholas Marowsky, Thomas J Nichols, et al.
Plos One|October 22, 2016
Correction: Environmental DNA Marker Development with Sparse Biological Information: A Case Study on Opossum Shrimp (Mysis diluviana)Kellie J Carim, Kyle R Christianson, Kevin M McKelvey, et al.
Blood|May 1, 1996
Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcomeP M Mauch, L A Kalish, K C Marcus, et al.
Cancer|November 1, 1996
Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapyI Gage, S J Schnitt, A J Nixon, et al.
Journal of the National Cancer Institute|December 19, 1990
Results of stereotactic brachytherapy used in the initial management of patients with glioblastomaJ S Loeffler, E Alexander, P Y Wen, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|June 1, 2001
Improved outcomes in stroke thrombolysis with pre-specified imaging criteriaB Silver, B Demaerschalk, J G Merino, et al.
Pageof 43

Showing results (381-390 of 428) with videos related to

Sort By:
Pageof 43
International Journal of Molecular Medicine|September 3, 2011
Inhibition of experimental auto-immune uveitis by the A3 adenosine receptor agonist CF101Sara Bar-Yehuda, Dror Luger, Avivit Ochaion, et al.
Journal of Autoimmunity|May 14, 2019
Interleukin 22 ameliorates neuropathology and protects from central nervous system autoimmunityMary J Mattapallil, Jennifer L Kielczewski, Carlos R Zárate-Bladés, et al.
Plos One|August 24, 2016
Environmental DNA Marker Development with Sparse Biological Information: A Case Study on Opossum Shrimp (Mysis diluviana)Kellie J Carim, Kyle R Christianson, Kevin M McKelvey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 13, 2012
The living eye "disarms" uncommitted autoreactive T cells by converting them to Foxp3(+) regulatory cells following local antigen recognitionRu Zhou, Reiko Horai, Phyllis B Silver, et al.
Experimental Gerontology|October 16, 2012
Curcumin is an early-acting stage-specific inducer of extended functional longevity in DrosophilaJung-Won Soh, Nicholas Marowsky, Thomas J Nichols, et al.
Plos One|October 22, 2016
Correction: Environmental DNA Marker Development with Sparse Biological Information: A Case Study on Opossum Shrimp (Mysis diluviana)Kellie J Carim, Kyle R Christianson, Kevin M McKelvey, et al.
Blood|May 1, 1996
Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcomeP M Mauch, L A Kalish, K C Marcus, et al.
Cancer|November 1, 1996
Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapyI Gage, S J Schnitt, A J Nixon, et al.
Journal of the National Cancer Institute|December 19, 1990
Results of stereotactic brachytherapy used in the initial management of patients with glioblastomaJ S Loeffler, E Alexander, P Y Wen, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|June 1, 2001
Improved outcomes in stroke thrombolysis with pre-specified imaging criteriaB Silver, B Demaerschalk, J G Merino, et al.
Pageof 43